Patients
Patients not just at the table, but creating their own: In c...
Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.
R&D
Gravity is an experimental variable pharma has rarely been a...
Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.
Digital
Sponsored
Antiviral development in the age of AI: From pre-IND to earl...
hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.
Market Access
Biotech's next growth cycle: Renewed confidence comes with c...
Renewed confidence across biopharma is welcome and long overdue after a prolonged period of constraint. But confidence alone is not enough.
Oncology
The future of oncology is adaptive: What ESMO 2026 revealed ...
Across tumours, three developments repeatedly surfaced throughout the congress, each reflecting a notable transition in how cancer is being managed.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
